Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Odelia Cooper"'
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Management of aggressive pituitary adenomas is challenging due to a paucity of rigorous evidence supporting available treatment approaches. Recent guidelines emphasize the need to maximize standard therapies as well as the use of temozolomide and rad
Externí odkaz:
https://doaj.org/article/f20a4e602f0d4dc3aeab27b1c89800d9
Publikováno v:
Frontiers in Endocrinology, Vol 10 (2019)
Externí odkaz:
https://doaj.org/article/5e345e0df9ee4d5491f7bf6676b8b200
Supplementary Figure 1 from Heregulin Regulates Prolactinoma Gene Expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae6622a0549a868ca8e5a6555ce9776f
https://doi.org/10.1158/0008-5472.22378253
https://doi.org/10.1158/0008-5472.22378253
Supplementary Table 1 from Heregulin Regulates Prolactinoma Gene Expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1c93352be5e721b83b9a1ddaa836a63
https://doi.org/10.1158/0008-5472.22378244
https://doi.org/10.1158/0008-5472.22378244
Supplementary Figure Legends 1-2 from Heregulin Regulates Prolactinoma Gene Expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e47a006feac33070be3e6351ed18309
https://doi.org/10.1158/0008-5472.22378247.v1
https://doi.org/10.1158/0008-5472.22378247.v1
Supplementary Figure 2 from Heregulin Regulates Prolactinoma Gene Expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b301adc97809c8785fc446a3e576c50e
https://doi.org/10.1158/0008-5472.22378250.v1
https://doi.org/10.1158/0008-5472.22378250.v1
Autor:
Odelia Cooper, Rita Lis, Vivien Bonert, Artak Labadzhyan, Ning-Ai Liu, Anat Ben-Shlomo, Vladimir Ljubimov, Viktoria Krutikova, Adam N Mamelak
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism.
ContextPostoperative hyponatremia leads to prolonged hospital length of stay and readmission within 30 days.ObjectiveTo assess 3 strategies for reducing rates of postoperative hyponatremia and analyze risk factors for hyponatremia.DesignTwo retrospec
Autor:
Odelia Cooper, Yona Greenman
Publikováno v:
Frontiers in Endocrinology, Vol 9 (2018)
Dopamine agonists (DA) are well established as first-line therapy for prolactinomas. These tumors express high levels of dopamine 2 receptors (D2R), leading to the strong efficacy of DA in reducing tumor size and hormonal secretion. Other pituitary t
Externí odkaz:
https://doaj.org/article/78845f1dd77f4220b8a2b7b8019ecc23
Autor:
Adam Mamelak, Vivien Bonert, Ning-Ai Liu, Anat BenShlomo, Artak Labadzhyan, Risha Malik, Albert Shamouelian, Odelia Cooper
Publikováno v:
Journal of the Endocrine Society. 6:A553-A554
Rationale: Hyponatremia occurs in approximately 20% of patients after transsphenoidal pituitary surgery (TSS). Symptomatic delayed hyponatremia from SIADH is a major cause of morbidity and hospital readmission. Prophylactic fluid restriction (FR) pro
Autor:
Barry D. Pressman, Vivien Bonert, Janet Lo, Maria Fleseriu, Shlomo Melmed, Odelia Cooper, Jeremy Rudnick, Roberto Salvatori, Kevin C J Yuen
Publikováno v:
J Clin Endocrinol Metab
Context Approximately 10% to 20% of prolactinomas are resistant to dopamine agonist therapy. The ErbB signaling pathway may drive aggressive prolactinoma behavior. Objective We evaluated lapatinib, an ErbB1-epidermal growth factor receptor (EGFR)/Erb